-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, V/0gVOM6QNH3H5+Oj8pJDKqahx/o9f1XTxS3GRLKuZB0jlqhMb+WB7S9ZQ5FDv+Y oo7QKtUg04M06OpDNHFRBg== 0001209191-09-044655.txt : 20090916 0001209191-09-044655.hdr.sgml : 20090916 20090916200103 ACCESSION NUMBER: 0001209191-09-044655 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090915 FILED AS OF DATE: 20090916 DATE AS OF CHANGE: 20090916 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MCLAUGHLIN JOHN PETER CENTRAL INDEX KEY: 0001277967 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19756 FILM NUMBER: 091073297 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PDL BIOPHARMA, INC. CENTRAL INDEX KEY: 0000882104 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943023969 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 932 SOUTHWOOD BLVD CITY: INCLINE VILLAGE STATE: NV ZIP: 89451 BUSINESS PHONE: 775-832-8500 MAIL ADDRESS: STREET 1: 932 SOUTHWOOD BLVD CITY: INCLINE VILLAGE STATE: NV ZIP: 89451 FORMER COMPANY: FORMER CONFORMED NAME: PROTEIN DESIGN LABS INC/DE DATE OF NAME CHANGE: 19930328 4 1 doc4.xml FORM 4 SUBMISSION X0303 4 2009-09-15 0 0000882104 PDL BIOPHARMA, INC. PDLI 0001277967 MCLAUGHLIN JOHN PETER C/O PDL BIOPHARMA, INC. 932 SOUTHWOOD BOULEVARD INCLINE VILLAGE NV 89451 1 1 0 0 President and CEO Common Stock 2009-09-15 4 M 0 13750 5.414 A 61666 D Common Stock 2009-09-15 4 M 0 2291 5.414 A 63957 D Common Stock 2009-09-15 4 M 0 916 5.414 A 64873 D Common Stock 2009-09-15 4 M 0 11458 5.414 A 76331 D Stock Option (Right to Buy) 5.414 2009-09-15 4 M 0 13750 0.00 D 2015-10-08 Common Stock 13750 1250 D Stock Option (Right to Buy) 5.414 2009-09-15 4 M 0 2291 0.00 D 2015-10-08 Common Stock 2291 209 D Stock Option (Right to Buy) 5.414 2009-09-15 4 M 0 916 0.00 D 2015-10-08 Common Stock 916 84 D Stock Option (Right to Buy) 5.414 2009-09-15 4 M 0 11458 0.00 D 2015-10-08 Common Stock 11458 13542 D The exercise price adjusted from $8.31 per share to $5.414 per share in connection with the spin-off of Facet Biotech Corporation. This option vests monthly at the rate of 1,250 per month until fully vested. This option vests monthly at the rate of approximately 208 shares per month until fully vested. This option vests monthly at the rate of approximately 83 shares per month until fully vested. This option vests monthly at the rate of approximately 1,042 shares per month until fully vested. This Form 4 reflects only the exercise of certain stock options and not a sale of the shares received upon exercise of the options. Christopher Stone by Christopher Stone, Attorney-in-Fact for John P. McLaughlin 2009-09-16 -----END PRIVACY-ENHANCED MESSAGE-----